Compare BOW & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOW | PACB |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 734.3M | 655.9M |
| IPO Year | 2024 | 2010 |
| Metric | BOW | PACB |
|---|---|---|
| Price | $34.21 | $2.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $34.33 | $2.79 |
| AVG Volume (30 Days) | 192.6K | ★ 12.6M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.26 | N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $551,589,000.00 | $93,468,000.00 |
| Revenue This Year | $21.49 | N/A |
| Revenue Next Year | $19.78 | $16.01 |
| P/E Ratio | $25.66 | ★ N/A |
| Revenue Growth | ★ 29.58 | 3.04 |
| 52 Week Low | $21.21 | $1.07 |
| 52 Week High | $35.07 | $3.44 |
| Indicator | BOW | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 57.12 | 52.96 |
| Support Level | $33.95 | $1.27 |
| Resistance Level | $34.51 | $3.07 |
| Average True Range (ATR) | 0.25 | 0.30 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 34.06 | 37.99 |
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.